TY - JOUR
T1 - Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
AU - Gehrtz, Paul
AU - Marom, Shir
AU - Bührmann, Mike
AU - Hardick, Julia
AU - Kleinbölting, Silke
AU - Shraga, Amit
AU - Dubiella, Christian
AU - Gabizon, Ronen
AU - Wiese, Jan N.
AU - Müller, Matthias P.
AU - Cohen, Galit
AU - Babaev, Ilana
AU - Shurrush, Khriesto
AU - Avram, Liat
AU - Resnick, Efrat
AU - Barr, Haim
AU - Rauh, Daniel
AU - London, Nir
AU - Bührmann, Mike
AU - Kleinbölting, Silke
AU - Müller, Matthias P.
N1 - Publisher Copyright: © 2022 American Chemical Society.
PY - 2022/8/11
Y1 - 2022/8/11
N2 - High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide-alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography-mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter.
AB - High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide-alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography-mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter.
UR - http://www.scopus.com/inward/record.url?scp=85136094887&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.1c02206
DO - 10.1021/acs.jmedchem.1c02206
M3 - مقالة
C2 - 35912476
SN - 0022-2623
VL - 65
SP - 10341
EP - 10356
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 15
ER -